How egg-freezing is keeping more women in the tech industry: The inside story
By Alison DeNisco,
Tech Republic [cites CGS' Marcy Darnovsky]
| 08. 15. 2017
Women leave jobs at mid-career in tech at higher rates than those in other fields. It's possible that benefits like egg freezing can improve female retention, but the procedure remains controversial.
At Brigitte Adams' last job in tech, an office lactation room was turned into a prayer room. "There were no pregnant women at the company, ever," she said. "I was surrounded by men in engineering departments. You didn't see other women."
In the summer of 2011, Adams had just left a multinational corporation to become a consultant. She was 39 years old and not yet married, and began thinking about making plans for a future family. "It was sort of a typical scenario of a single career woman who really wanted kids," she said. Being a tech-minded person, she turned to a procedure that was at the time still labeled experimental: Egg freezing. Also known as oocyte cryopreservation, egg freezing is a process in which a woman's eggs are extracted, frozen, and stored for future use, as a way to preserve their reproductive potential.
It's been nearly three...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026